Faster, cheaper, and more accurate ... Scalable AI for breast cancer screening.

  • Stage Prototype Ready
  • Industry Healthcare Services
  • Location Sydney NSW, Australia
  • Currency AUD
  • Founded September 2017
  • Employees 2
  • Incorporation Type LLC
  • Website

Company Summary

Alixir is a healthtech company that applies deep learning to improve healthcare efficiency and outcomes. Our launch product AIMS provides a scalable mammogram analyser at significantly lower cost - yet higher accuracy - than what can currently be provided by radiologists. As a result we can make existing breast screen programs more cost-effective, save even more lives, and perhaps one day enable their introduction into developing countries too.


  • Co-founder, CTO

    A qualified medical doctor with over two decades’ experience in machine learning. Currently doing a PhD in applied deep learning in mammography.

  • Jim Harding

    A market disrupter with roots going back to the original team that developed DOS and sold it to Microsoft, Jim was the VP of Technology at Amazon where he led the team that developed the technology platform for the Marketplace. He also founded ServerWare (which sold to Microsoft as part of SQL Server), as well as running Cartia, an award-winning pioneer in early big data machine learning techniques.

  • Cliff Monlux
    Board Advisor

    Over 25 years experience starting, growing, investing, and selling market leading technology companies. As a founder of Paradigm Technology Partners he helped launch such companies as Docusign, and has been involved in launching and financing companies which have created more than US$12 Billion in market value. Currently a managing partner at Ramp Equity Partners.


  • Sebastien Eckersley-Maslin

Previous Investors

  • Artesian

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free